scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.JSAT.2011.01.007 |
P8608 | Fatcat ID | release_b5wdkzgc2rebzg5l6ytxcvy2ku |
P932 | PMC publication ID | 3110534 |
P698 | PubMed publication ID | 21349679 |
P5875 | ResearchGate publication ID | 50195734 |
P50 | author | Peter Francis Rebeiro | Q42707320 |
Catherine C. McGowan | Q83393370 | ||
Timothy R. Sterling | Q90048402 | ||
Todd M. Hulgan | Q91233130 | ||
Samuel E Stinnette | Q124366605 | ||
P2093 | author name string | Bryan E Shepherd | |
Aaron M Kipp | |||
Han-Zhu Qian | |||
Cathy A Jenkins | |||
Charles P Samenow | |||
Paul No | |||
P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults | Q28184343 | ||
Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004 | Q28474749 | ||
Drug use and medication adherence among HIV-1 infected individuals | Q33841530 | ||
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies | Q34139859 | ||
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users | Q34743004 | ||
The relationship between non-injection drug use behaviors on progression to AIDS and death in a cohort of HIV seropositive women in the era of highly active antiretroviral therapy use. | Q35082895 | ||
Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview | Q36063045 | ||
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies | Q36285986 | ||
Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. | Q36492802 | ||
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST). | Q36906185 | ||
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. | Q37104874 | ||
Mortality and causes and manner of death among drug addicts in Stockholm during the period 1981-1992. | Q39452989 | ||
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection | Q39574163 | ||
Medical care for injection-drug users with human immunodeficiency virus infection | Q40674545 | ||
Mortality trends in a cohort of opiate addicts, Catalonia, Spain | Q43690785 | ||
Impact of HIV infection on mortality in a cohort of injection drug users | Q43798771 | ||
Effect of hard-drug use on CD4 cell percentage, HIV RNA level, and progression to AIDS-defining class C events among HIV-infected women | Q45106342 | ||
Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users | Q46084194 | ||
The lack of association of marijuana and other recreational drugs with progression to AIDS in the San Francisco Men's Health Study | Q46158536 | ||
Psychiatric morbidity, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease | Q46674972 | ||
Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use. | Q47990033 | ||
Barriers to use of free antiretroviral therapy in injection drug users | Q50159275 | ||
Study of 2708 heroin-related deaths in north-eastern Italy 1985-98 to establish the main causes of death. | Q50680029 | ||
How do physicians define "light," "moderate," and "heavy" drinking? | Q50868009 | ||
Absolute count and percentage of CD4+ lymphocytes are independent predictors of disease progression in HIV-infected persons initiating highly active antiretroviral therapy. | Q51771547 | ||
Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users | Q58310883 | ||
Differences in HIV disease progression by injecting drug use in HIV-infected persons in care | Q75225425 | ||
Causes of death among crack cocaine users | Q79298251 | ||
Effect of persistent moderate viremia on disease progression during HIV therapy | Q80471687 | ||
P433 | issue | 1 | |
P304 | page(s) | 14-20 | |
P577 | publication date | 2011-02-23 | |
P1433 | published in | Journal of Substance Abuse Treatment | Q15762042 |
P1476 | title | The relationship between injection and noninjection drug use and HIV disease progression | |
P478 | volume | 41 |